Document Detail


How injection drug users coped with testing HIV-seropositive: implications for subsequent health-related behaviors.
MedLine Citation:
PMID:  11459357     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
At entry into methadone maintenance treatment, 94 HIV-positive injection drug users (IDUs) completed the Coping Reponses Inventory, which asked them to "describe your feelings and experiences when you first learned you were HIV positive." Controlling for time since HIV testing, a reliance on avoidance coping following HIV testing was correlated with high levels of recent HIV risk behavior and poor health at entry into the study. The use of any coping strategy, particularly approach strategies, was related to medication adherence. Hierarchical regression analysis showed that avoidance coping accounted for a significant proportion of the variance in recent HIV risk behavior over and above that accounted for by the other variables. Other independent predictors of continued risk behavior were poor health, lack of social support, and low levels of HIV/AIDS knowledge. The need for interventions to help injection drug users (IDUs) cope subsequent to testing HIV seropositive is discussed.
Authors:
S K Avants; L A Warburton; A Margolin
Related Documents :
20705967 - Hiv and proteinuria in an injection drug user population.
605897 - Granulomatous hepatitis in a healthy adult following bcg injection into a plantar wart.
15845317 - Hiv infection among female drug users in northern thailand.
9629827 - Health care costs of a continuing epidemic of hepatitis c virus infection among injecti...
21660187 - Modulation of hiv binding to epithelial cells and hiv transfer from immature dendritic ...
22294367 - Studies on hepatitis c virus resistance to inhibitors in replicon systems.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  AIDS education and prevention : official publication of the International Society for AIDS Education     Volume:  13     ISSN:  0899-9546     ISO Abbreviation:  AIDS Educ Prev     Publication Date:  2001 Jun 
Date Detail:
Created Date:  2001-07-18     Completed Date:  2001-12-05     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9002873     Medline TA:  AIDS Educ Prev     Country:  United States    
Other Details:
Languages:  eng     Pagination:  207-18     Citation Subset:  IM; X    
Affiliation:
Yale University School of Medicine, Division of Substance Abuse, New Haven, CT 06519, USA. kelly.avants@yale.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acquired Immunodeficiency Syndrome / complications
Adaptation, Psychological*
Adult
Data Interpretation, Statistical
Education
Female
HIV Seropositivity* / complications,  psychology
Health Behavior*
Humans
Male
Methadone / therapeutic use
Narcotics / therapeutic use
Personality Assessment
Regression Analysis
Risk-Taking
Social Support
Substance Abuse, Intravenous* / complications,  drug therapy,  psychology
Grant Support
ID/Acronym/Agency:
K21-DA00277/DA/NIDA NIH HHS; P50-DA09241/DA/NIDA NIH HHS; R01-DA10851/DA/NIDA NIH HHS
Chemical
Reg. No./Substance:
0/Narcotics; 76-99-3/Methadone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Factors associated with HIV-infected women's use or intention to use AZT during pregnancy.
Next Document:  Public reactions to people with HIV/AIDS in The Netherlands.